{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:07:02Z","timestamp":1773349622467,"version":"3.50.1"},"reference-count":69,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Real-world data on management and outcomes of patients with simultaneously diagnosed synchronous colorectal liver and lung metastases are limited. This national study evaluated referral patterns, treatment strategies, and survival in a population-based cohort.Patient\/material and methods: This retrospective cohort study used Swedish national registries to identify patients with synchronous liver and lung metastatic colorectal cancer (CRC), defined as metastases detected within 6 months of CRC diagnosis between 2008 and 2016. Medical record review provided additional information on diagnosis confirmation, multidisciplinary team (MDT) referral, metastatic burden, and treatment. Logistic regression identified factors associated with MDT referral and curative treatment, and Cox regression with a time-varying covariate assessed survival.Results: Among 2703 registry-identified patients, medical records were accessible for 855. After exclusion of extrahepatic, non-pulmonary metastases, 556 remained for analysis. A total of 189 patients (34%) were discussed at a liver MDT conference. Referred patients were younger, had lower metastatic burden, and better performance status than non-referred. Median survival was 24 months (95% CI [confidence interval] 21\u201328) for referred versus 10 months (95% CI 7\u201312) for non-referred patients. Curative local treatment of liver and\/or lung metastases was performed in 101 patients (18%), and complete metastasectomy in\u00a034\u00a0(6%), conferring superior survival compared with liver-only intervention (hazard ratio 0.34, 95% CI\u00a00.18\u20130.61). The main reason for non-referral was presumed non-resectability.Interpretation: Referral to an MDT and subsequent local treatment were associated with improved survival, although this may partly reflect favorable patient and tumor characteristics influencing referral and treatment decisions. Patients with adequate physiological reserve should routinely be evaluated in an organ-specific MDT for potential curative treatment.<\/jats:p>","DOI":"10.2340\/1651-226x.2026.45045","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:32:54Z","timestamp":1773311574000},"page":"201-212","source":"Crossref","is-referenced-by-count":0,"title":["Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer \u2013 a national cohort study"],"prefix":"10.2340","volume":"65","author":[{"given":"Laia","family":"Faseh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"Fruhling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-5250","authenticated-orcid":false,"given":"Helena","family":"Taflin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8865-9963","authenticated-orcid":false,"given":"Jenny","family":"Lundmark Rystedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9743-3149","authenticated-orcid":false,"given":"Caroline","family":"Williamsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-168X","authenticated-orcid":false,"given":"Oskar","family":"Hemmingsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-1260","authenticated-orcid":false,"given":"Bergthor","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-0662","authenticated-orcid":false,"given":"Marco","family":"Gerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-8328","authenticated-orcid":false,"given":"Ernesto","family":"Sparrelid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-9528","authenticated-orcid":false,"given":"Per","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-1588","authenticated-orcid":false,"given":"Kristina","family":"Hasselgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1123-7022","authenticated-orcid":false,"given":"Jennie","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"144269","doi-asserted-by":"crossref","unstructured":"Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729\u201341.","DOI":"10.1016\/j.ctrv.2015.06.006"},{"key":"144270","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctrv.2015.06.006","DOI":"10.1016\/j.ctrv.2015.06.006"},{"key":"144271","doi-asserted-by":"crossref","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","DOI":"10.1016\/j.annonc.2022.10.003"},{"key":"144272","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003","DOI":"10.1016\/j.annonc.2022.10.003"},{"key":"144273","doi-asserted-by":"crossref","unstructured":"van der Geest LG, Lam-Boer J, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457\u201365.","DOI":"10.1007\/s10585-015-9719-0"},{"key":"144274","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s10585-015-9719-0","DOI":"10.1007\/s10585-015-9719-0"},{"key":"144275","doi-asserted-by":"crossref","unstructured":"Engstrand J, Taflin H, Rystedt JL, Hemmingsson O, Urdzik J, Sandstr\u00f6m P, et al. The resection rate of synchronously detected liver and lung metastasis from colorectal cancer is low \u2013 a national registry-based study. Cancers (Basel). 2023;15(5):1434.","DOI":"10.3390\/cancers15051434"},{"key":"144276","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/cancers15051434","DOI":"10.3390\/cancers15051434"},{"key":"144277","doi-asserted-by":"crossref","unstructured":"V\u00e4yrynen V, Wirta EV, Sepp\u00e4l\u00e4 T, Sihvo E, Mecklin JP, Vasala K, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open. 2020;4(4):685\u201392.","DOI":"10.1002\/bjs5.50299"},{"key":"144278","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/bjs5.50299","DOI":"10.1002\/bjs5.50299"},{"key":"144279","doi-asserted-by":"crossref","unstructured":"Storli PE, Dille-Amdam RG, Skjerseth GH, Gran MV, Myklebust TA, Gronbech JE, et al. Synchronous metastases from colorectal cancer. Treatment and long-term survival compared to patients with metachronous metastases: a population-based study from Central Norway 2001\u20132015. Acta Oncol. 2025;64:797\u2013806.","DOI":"10.2340\/1651-226X.2025.42985"},{"key":"144280","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2025.42985","DOI":"10.2340\/1651-226X.2025.42985"},{"key":"144281","doi-asserted-by":"crossref","unstructured":"Dave RV, Pathak S, White AD, Hidalgo E, Prasad KR, Lodge JP, et al. Outcome after liver resection in patients presenting with simultaneous hepatopulmonary colorectal metastases. Br J Surg. 2015;102(3):261\u20138.","DOI":"10.1002\/bjs.9737"},{"key":"144282","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/bjs.9737","DOI":"10.1002\/bjs.9737"},{"key":"144283","doi-asserted-by":"crossref","unstructured":"Andres A, Mentha G, Adam R, Gerstel E, Skipenko OG, Barroso E, et al. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br J Surg. 2015;102(6):691\u20139.","DOI":"10.1002\/bjs.9783"},{"key":"144284","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/bjs.9783","DOI":"10.1002\/bjs.9783"},{"key":"144285","doi-asserted-by":"crossref","unstructured":"Matsumura M, Yamashita S, Ishizawa T, Akamatsu N, Kaneko J, Arita J, et al. Oncological benefit of complete metastasectomy for simultaneous colorectal liver and lung metastases. Am J Surg. 2020;219(1):80\u20137.","DOI":"10.1016\/j.amjsurg.2019.06.007"},{"key":"144286","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.amjsurg.2019.06.007","DOI":"10.1016\/j.amjsurg.2019.06.007"},{"key":"144287","doi-asserted-by":"crossref","unstructured":"Engstrand J, Sterner J, Hasselgren K, Stromberg C, Sturesson C. Treatment intention and outcome in patients with simultaneously diagnosed liver and lung metastases from colorectal cancer. Eur J Surg Oncol. 2022;48(8):1799\u2013806.","DOI":"10.1016\/j.ejso.2022.03.006"},{"key":"144288","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejso.2022.03.006","DOI":"10.1016\/j.ejso.2022.03.006"},{"key":"144289","doi-asserted-by":"crossref","unstructured":"Siebenh\u00fcner AR, G\u00fcller U, Warschkow R. Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases. BMC Cancer. 2020;20(1):246.","DOI":"10.1186\/s12885-020-6710-1"},{"key":"144290","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12885-020-6710-1","DOI":"10.1186\/s12885-020-6710-1"},{"key":"144291","doi-asserted-by":"crossref","unstructured":"Moberger P, Sk\u00f6ldberg F, Birgisson H. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity. Acta Oncol. 2018;57(12):1611\u201321.","DOI":"10.1080\/0284186X.2018.1529425"},{"key":"144292","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2018.1529425","DOI":"10.1080\/0284186X.2018.1529425"},{"key":"144293","unstructured":"T\u00e4ckningsgrader f\u00f6r nationella Kvalitetsregister 2020 .Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2020-12-7049.pdf"},{"key":"144294","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"144295","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"144296","doi-asserted-by":"crossref","unstructured":"Snapinn SM, Qi J, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat. 2005;59(4):301\u20137.","DOI":"10.1198\/000313005X70371"},{"key":"144297","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1198\/000313005X70371","DOI":"10.1198\/000313005X70371"},{"key":"144298","doi-asserted-by":"crossref","unstructured":"Sj\u00f6lander A. A cautionary note on extended Kaplan-Meier curves for time-varying covariates. Epidemiology. 2020;31(4):517\u201322.","DOI":"10.1097\/EDE.0000000000001188"},{"key":"144299","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/EDE.0000000000001188","DOI":"10.1097\/EDE.0000000000001188"},{"key":"144300","doi-asserted-by":"crossref","unstructured":"Mas L, Bachet JB, Jooste V, Lepage C, Bouvier AM. Chemotherapy of metastatic colon cancer in France: a population-based study. Dig Liver Dis. 2021;53(10):1334\u201342.","DOI":"10.1016\/j.dld.2021.03.019"},{"key":"144301","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.dld.2021.03.019","DOI":"10.1016\/j.dld.2021.03.019"},{"key":"144302","doi-asserted-by":"crossref","unstructured":"Noren A, Sandstrom P, Gunnarsdottir K, Ardnor B, Isaksson B, Lindell G, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden. Scand J Surg. 2018;107(4):294\u2013301.","DOI":"10.1177\/1457496918766706"},{"key":"144303","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1457496918766706","DOI":"10.1177\/1457496918766706"},{"key":"144304","doi-asserted-by":"crossref","unstructured":"Almlov K, Arbman G, Bjornsson B, Elander NO, Hager J, Hamid S, et al. Assessment by a multidisciplinary team conference affects treatment strategy and overall survival in patients with synchronous colorectal liver metastases. HPB (Oxford). 2024;26(9):1131\u201340.","DOI":"10.1016\/j.hpb.2024.05.008"},{"key":"144305","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.hpb.2024.05.008","DOI":"10.1016\/j.hpb.2024.05.008"},{"key":"144306","doi-asserted-by":"crossref","unstructured":"Isoniemi H, Uutela A, Nordin A, Lantto E, Kellokumpu I, Ovissi A, et al. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study. Br J Surg. 2021;108(7):817\u201325.","DOI":"10.1093\/bjs\/znaa145"},{"key":"144307","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/bjs\/znaa145","DOI":"10.1093\/bjs\/znaa145"},{"key":"144308","doi-asserted-by":"crossref","unstructured":"Thillai K, Repana D, Korantzis I, Prachalias A, Kane P, Ross PJ. Clinical outcomes for patients with liver-limited metastatic colorectal cancer: arguing the case for specialist hepatobiliary multidisciplinary assessment. Eur J Surg Oncol. 2016;42(9):1331\u20136.","DOI":"10.1016\/j.ejso.2016.03.031"},{"key":"144309","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejso.2016.03.031","DOI":"10.1016\/j.ejso.2016.03.031"},{"key":"144310","doi-asserted-by":"crossref","unstructured":"t Lam-Boer J, van der Stok EP, Huiskens J, Verhoeven RH, Punt CJ, Elferink MA, et al. Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands. Eur J Cancer. 2017;71:109\u201316.","DOI":"10.1016\/j.ejca.2016.10.026"},{"key":"144311","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejca.2016.10.026","DOI":"10.1016\/j.ejca.2016.10.026"},{"key":"144312","doi-asserted-by":"crossref","unstructured":"Huiskens J, Bolhuis K, Engelbrecht MR, De Jong KP, Kazemier G, Liem MS, et al. Outcomes of resectability assessment of the Dutch Colorectal Cancer Group liver metastases expert panel. J Am Coll Surg. 2019;229(6):523\u201332.e2.","DOI":"10.1016\/j.jamcollsurg.2019.08.1445"},{"key":"144313","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.08.1445","DOI":"10.1016\/j.jamcollsurg.2019.08.1445"},{"key":"144314","doi-asserted-by":"crossref","unstructured":"Engstrand J, Kartalis N, Stromberg C, Broberg M, Stillstrom A, Lekberg T, et al. The impact of a hepatobiliary multidisciplinary team assessment in patients with colorectal cancer liver metastases: a population-based study. Oncologist. 2017;22(9):1067\u201374.","DOI":"10.1634\/theoncologist.2017-0028"},{"key":"144315","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1634\/theoncologist.2017-0028","DOI":"10.1634\/theoncologist.2017-0028"},{"key":"144316","doi-asserted-by":"crossref","unstructured":"Hellingman T, de Swart ME, Joosten JJA, Meijerink MR, de Vries JJJ, de Waard JWD, et al. The value of a dedicated multidisciplinary expert panel to assess treatment strategy in patients suffering from colorectal cancer liver metastases. Surg Oncol. 2020;35:412\u201317.","DOI":"10.1016\/j.suronc.2020.09.024"},{"key":"144317","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.suronc.2020.09.024","DOI":"10.1016\/j.suronc.2020.09.024"},{"key":"144318","doi-asserted-by":"crossref","unstructured":"van der Ven R, Westra D, van Erning FN, de Hingh IH, Olde Damink SWM, Paulus A, et al. The impact of a multi-hospital network on the inequality in odds of receiving resection or ablation for synchronous colorectal liver metastases. Acta Oncol. 2023;62(8):842\u201352.","DOI":"10.1080\/0284186X.2023.2238545"},{"key":"144319","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2023.2238545","DOI":"10.1080\/0284186X.2023.2238545"},{"key":"144320","doi-asserted-by":"crossref","unstructured":"Torzilli G, McCormack L, Pawlik T. Parenchyma-sparing liver resections. Int J Surg. 2020;82S:192\u20137.","DOI":"10.1016\/j.ijsu.2020.04.047"},{"key":"144321","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.047","DOI":"10.1016\/j.ijsu.2020.04.047"},{"key":"144322","doi-asserted-by":"crossref","unstructured":"Tinguely P, Ruiter SJS, Engstrand J, de Haas RJ, Nilsson H, Candinas D, et al. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC). Eur J Cancer. 2023;187:65\u201376.","DOI":"10.1016\/j.ejca.2023.03.038"},{"key":"144323","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.038","DOI":"10.1016\/j.ejca.2023.03.038"},{"key":"144324","doi-asserted-by":"crossref","unstructured":"van der Lei S, Puijk RS, Dijkstra M, Schulz HH, Vos DJW, De Vries JJJ, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26(2):187\u201399.","DOI":"10.1016\/S1470-2045(24)00660-0"},{"key":"144325","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(24)00660-0","DOI":"10.1016\/S1470-2045(24)00660-0"},{"key":"144326","doi-asserted-by":"crossref","unstructured":"Dong T, Fan H, Lyu J, Shi Y, Hu P, Wu X, et al. A retrospective study comparing the efficacy of microwave ablation and stereotactic body radiotherapy in colorectal cancer lung metastases. Oncol Lett. 2024;28(1):322.","DOI":"10.3892\/ol.2024.14455"},{"key":"144327","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3892\/ol.2024.14455","DOI":"10.3892\/ol.2024.14455"},{"key":"144328","doi-asserted-by":"crossref","unstructured":"Ogawa H, Yajima T, Sohda M, Shirabe K, Saeki H. Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer. Ann Gastroenterol Surg. 2021;5(6):747\u201353.","DOI":"10.1002\/ags3.12472"},{"key":"144329","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ags3.12472","DOI":"10.1002\/ags3.12472"},{"key":"144330","doi-asserted-by":"crossref","unstructured":"Adam R, Piedvache C, Chiche L, Adam JP, Salame E, Bucur P, et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. Lancet. 2024;404(10458):1107\u201318.","DOI":"10.2139\/ssrn.4830489"},{"key":"144331","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(24)01595-2","DOI":"10.1016\/S0140-6736(24)01595-2"},{"key":"144332","doi-asserted-by":"crossref","unstructured":"Valdimarsson VT, Syk I, Lindell G, Sandstr\u00f6m P, Isaksson B, Rizell M, et al. Outcomes of simultaneous resections and classical strategy for synchronous colorectal liver metastases in Sweden: a nationwide study with special reference to major liver resections. World J Surg. 2020;44(7):2409\u201317.","DOI":"10.1007\/s00268-020-05475-5"},{"key":"144333","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00268-020-05475-5","DOI":"10.1007\/s00268-020-05475-5"},{"key":"144334","doi-asserted-by":"crossref","unstructured":"Fr\u00fchling P, Str\u00f6mberg C, Isaksson B, Urdzik J. A comparison of the simultaneous, liver-first, and colorectal-first strategies for surgical treatment of synchronous colorectal liver metastases at two major liver-surgery institutions in Sweden. HPB (Oxford). 2023;25(1):26\u201336.","DOI":"10.1016\/j.hpb.2022.09.001"},{"key":"144335","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.hpb.2022.09.001","DOI":"10.1016\/j.hpb.2022.09.001"},{"key":"144336","doi-asserted-by":"crossref","unstructured":"Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330\u201379.","DOI":"10.1067\/j.cpsurg.2018.08.004"},{"key":"144337","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1067\/j.cpsurg.2018.08.004","DOI":"10.1067\/j.cpsurg.2018.08.004"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45045\/53137","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45045\/53137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:33:30Z","timestamp":1773311610000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/45045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":69,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2026.45045","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}